Eagle Rock Investment Company LLC Has $7.11 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Eagle Rock Investment Company LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 13,565 shares of the healthcare conglomerate’s stock after purchasing an additional 120 shares during the quarter. UnitedHealth Group accounts for approximately 1.2% of Eagle Rock Investment Company LLC’s investment portfolio, making the stock its 21st biggest position. Eagle Rock Investment Company LLC’s holdings in UnitedHealth Group were worth $7,105,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Snider Financial Group boosted its holdings in shares of UnitedHealth Group by 7.2% during the 1st quarter. Snider Financial Group now owns 7,053 shares of the healthcare conglomerate’s stock valued at $3,694,000 after acquiring an additional 473 shares in the last quarter. Littlejohn Financial Services Inc. increased its position in UnitedHealth Group by 4.1% in the 1st quarter. Littlejohn Financial Services Inc. now owns 4,140 shares of the healthcare conglomerate’s stock valued at $2,168,000 after buying an additional 162 shares in the last quarter. Next Level Private LLC bought a new stake in UnitedHealth Group in the 1st quarter valued at about $203,000. Magnus Financial Group LLC increased its position in UnitedHealth Group by 1.5% in the 1st quarter. Magnus Financial Group LLC now owns 5,046 shares of the healthcare conglomerate’s stock valued at $2,643,000 after buying an additional 73 shares in the last quarter. Finally, Intellectus Partners LLC boosted its stake in UnitedHealth Group by 13.3% during the 1st quarter. Intellectus Partners LLC now owns 2,566 shares of the healthcare conglomerate’s stock valued at $1,344,000 after purchasing an additional 301 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a research note on Monday, May 19th. Morgan Stanley dropped their price objective on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Robert W. Baird dropped their price objective on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 14th. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Finally, Mizuho lowered their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $428.43.

UnitedHealth Group Stock Up 2.5%

Shares of NYSE:UNH opened at $303.24 on Friday. The stock’s 50-day moving average price is $409.03 and its 200-day moving average price is $484.21. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The stock has a market capitalization of $275.08 billion, a P/E ratio of 19.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the business posted $6.91 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s dividend payout ratio is presently 37.02%.

Insider Buying and Selling

In other news, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO John F. Rex purchased 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now directly owns 203,796 shares of the company’s stock, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock valued at $31,607,768 over the last three months. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.